UK CRO Quotient Bioresearch has bought a clinical research facility in Edinburgh, Scotland, which in conjunction with an existing unit in Nottingham, England will serve as a base for its new Quotient Clinical unit.
BerGenBio is at BIO 2009 presenting its CellSelectRNAi technology and other services, which in the four months the company has been operational have landed it a multi-million dollar deal with a "big blue-chip pharma".
CRO Encorium has unveiled plans to sell both its US business and its Finnish subsidiary Encorium Oy just weeks after posting a gloomy set of Q1 financials dominated by a 15 per cent drop in net revenues.
Perceptive Informatics has expanded its offering for trials involving Alzheimer's disease with a new medical imaging method, which it claims produces higher quality, reproducible and regulatory compliant assessments.
US contract research organisation (CRO) Encorium has reported $2m in new and repeat business deals on the same day it posted gloomy Q4 figures and cited the "drop in demand" refrain heard across the trial sector.
US software giant Microsoft has unveiled its new Amalga Life Sciences data aggregation and modelling platform in a bid to capitalise on the demand for IT infrastructure solutions currently sweeping the drug R&D and trials sectors.
US clinical trials firm ChemDiv has bought Russian CRO Prudentas, boosting its presence in the country at a time when the treatment naïve populations in Eastern Europe are increasingly catching the eye of the global pharma and biotech industries.
From June onwards drug firms and CROs conducting trials in India are required to record full details of the research, including the funding source, on the ICMR’s Clinical Trials Registry India website.
Cincinnati, US site management organisation (SMO) Radiant Research says that growing industry demand for trials outside the US is the key motivation for the link up with India’s Spectrum Clinical Research.
Pfizer has become the first drugmaker to win accreditation for protecting the human rights of subjects enrolled into early-stage clinical trials under a scheme operated by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).
With M&A activity dominating Big Pharma's agenda at the moment, the contract research market is having to evolve and adapt to the turbulent environmnet. Outsourcing-pharma asked Frost & Sullivan analyst Barath Shankar to offer his opinion...
US CRO PharmaNet hopes its new trial staffing service will provide an additional revenue stream and help stave-off plummeting 2008 incomes and compensate for a series of painful contract cancellations.
Cardiology and eClinical specialist eResearch Technology missed analysts estimates of sales and earnings in the fourth quarter of 2008, but still posted a near-14 per cent increase in operating profit.
Synexus' new trial site in Bulgaria, which is part of the firm’s clinical research centre strategy, will help sponsors cut development times and significantly reduce costs, according to CEO Michael Fort.
Study site operators want greater use of EDC technologies and more pharma industry investment to boost patient recruitment and reduce delays in clinical trials, according to an industry report due to be published next week.
Contract research organisation Bio-Imaging Technologies posted a 48 per cent hike on revenues in the fourth quarter of 2008, but still made a small net loss on the back of its CapMed division, which was sold last month.
US software specialist etrials Worldwide has added Belgian rival Unithink to an ongoing lawsuit that accuses two former executives, Robert Sammis and Brendon Ball, of breaching confidentiality agreements.
Charles River Laboratories will reduce its workforce by 3 per cent, close its preclinical facility in Arkansas, US and sell off its Phase I trial site in Edinburgh, Scotland as part of a cost reduction programme.
Compass Pharma Services is targeting contract drug developers and clinical research firms with a new microfilling offering that, it claims, helps reduce waste and may even make excipients unnecessary in some drugs.
US company PRA International has entered into a strategic collaboration with two contract research organizations (CROs) in Southeast Asia in order to tap the fast-growing clinical research market in the region.
Contract research organisation Bio-Imaging Technologies has decided to sell off its CapMed subsidiary in order to focus its efforts on its core business, providing imaging series to clinical investigators.
There is no formal requirement to inform clinical trial participants of the results of the study, a situation which can leave them “confused, frustrated and, in some cases, lacking information that may be important to their health,” according to a report...
Icon's recent $43.2m acquisition of New York-based Prevalere Life Sciences is the latest part of the firm's expansion in the US CRO market. Outsourcing-Pharma spoke with Icon's VP of bioanalytical development, Brian O'Dwyer, and Prevalere...